Marina Biotech, Inc. - Strategy, SWOT and Corporate Finance Report
Marina Biotech, Inc. - Strategy, SWOT and Corporate Finance ReportSummary
Marina Biotech, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
Key Highlights
Marina Biotech, Inc. (Marina Biotech or ‘the company’) is a biotechnology company focused on the development and commercialization of nucleic acid-based therapies to treat orphan diseases. The company provides drugs to treat hypertension, arthritis, pain and others. The company offers Prestalia, a single-pill fixed dose combination and amlodipine besylate, a calcium channel blocker for the treatment of hypertension. Its clinical development programs include IT-102 and IT-103, a celecoxib program drug for the treatment of combined arthritis pain/hypertension and the treatment of pain requiring a high dose of celecoxib; CEQ508, an oral delivery of small interfering RNA against beta-catenin, combined with IT-102 to for familial adenomatous polyposis; and CEQ508 combined with IT-103 to treat colorectal cancer. The company is into research and development of pipeline products. Marina Biotech is headquartered in City of Industry, California, the US.
Scope
- Detailed information on Marina Biotech, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Marina Biotech, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Marina Biotech, Inc. including a breakdown and examination of key business segments
- Intelligence on Marina Biotech, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Marina Biotech, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of Marina Biotech, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Marina Biotech, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Marina Biotech, Inc.'s business structure, strategy and prospects.
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.